AdminDec 9, 2020< 1 min read

Synthetic Clinical Trial Data: Use Cases, Methods, and Experiences

2020-12-09-Synthetic-Clinical-Trial-Data-Use-Cases-Methods-and-Experiences

Stephen Bamford, Head of Clinical Data Standards & Transparency; IDAR, Global Development, Janssen

Sharing experiences with the synthesis of clinical trial data and how that data has been used by a pharmaceutical company.

View Video

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.

Learn More

AetionJun 5, 20258 min read

When Clinical Trials Stall, Evidence Shouldn't: How Generative Models Restore Power to Under-Enrolled Studies

Lucy Mosquera, MS, and Natalie Schibell, MPH Understanding the Impact of Incomplete Trials A growing share of clinical trials ...

Start Reading

AetionJun 3, 20257 min read

Real-World Evidence at Every Stage – How Aetion Powers the Drug Development Lifecycle

Natalie Schibell, MPH and Ashley Jaksa, MPH

Start Reading

AetionMay 29, 20254 min read

Built for Scientific Rigor: How Aetion Delivers Methodologically Defensible Real-World Evidence

Debra E. Irwin, PhD, MSPH, Amanda Kong, DrPH, and Natalie Schibell, MPH

Start Reading

SOFTWARE

SERVICES

PARTNERSHIPS

Synthetic Clinical Trial Data: Use Cases, Methods, and Experiences

RELATED ARTICLES

When Clinical Trials Stall, Evidence Shouldn't: How Generative Models Restore Power to Under-Enrolled Studies

Real-World Evidence at Every Stage – How Aetion Powers the Drug Development Lifecycle

Built for Scientific Rigor: How Aetion Delivers Methodologically Defensible Real-World Evidence